BIOTECH100
A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

Santarus Inc.

About Santarus Inc

Santarus is a specialty pharmaceutical company focused on acquiring, developing and commercializing proprietary products to enhance the quality of life for patients with gastrointestinal diseases and disorders.

Their current efforts are focused on the commercialization of ZEGERIDô. ZEGERID is a proprietary next generation proton pump inhibitor, or PPI. PPIs are the most frequently prescribed drugs for the treatment of many upper gastrointestinal, or GI, diseases and disorders.

 

 

PRODUCT DATA

 

ZEGERID -- Heartburn/GERD, Erosive esophagitis, Duodenal ulcers

 

 

 

Home Page

Key Statistics for Santarus

Basic Chart for Santarus

Analyst Opinion

Analysts Estimates

 
Biotech100 Index
What are the Requirements to be listed in the Biotech100 Index?
See the Biotech100 List

Sponsored Links

Clinical Trials
What is a Clinical Trial?
Phase I ,-- Phase II, -- PhaseIII
What is Randomized Control?
 What is a Double Blind Experiment?
What is the role of the FDA?

 

Key Biotech Terms

 

Biotech Resources

 

Investing in Stocks
Small Cap Stocks
Stocks and Bonds
Biotech100 Index

Careers and Employment
Biotechnology and Pharmaceutical
What are the Fastest Growing Careers?

 

Google
 
Web www.biotech100.com
SEARCH THE BIOTECH100 WEBSITE
  
     

 


Copyright © 2005 BIOTECH100.COM. All rights reserved.

email: info@biotech100.com